Short excerpt from a YouTube video discussing the therapeutic potential of exosomes for treating Alzheimer’s disease framed as a form of diabetes (‘type 3’). The speaker suggests reducing systemic inflammation and promoting neurogenesis and angiogenesis may improve outcomes, and highlights intranasal delivery as a route to reach the bloodstream and central nervous system via olfactory and trigeminal pathways.
We know now, Alzheimer's is, in essence, it's a type of diabetes. Right? Diabetes type 3. Hey, what are we able to do? If we're able to kind of bring down that systemic inflammation and we're able to help create new neurogenesis and angiogenesis, are we able to improve that? And I'm hoping in time to tell, but it is. It is promising. What are the exosomes actually doing to cause such a dramatic healing effect? Well, if you think that intranasal delivery, the nasal mucosa is very well vascularized area, right? So it provides a direct pathway to the bloodstream and even the central nervous system through the olfactory nerve and the trigeminal nerve pathway.
The Solution to Aging Might Be Closer Than Anyone Realizes - With Ben Goertzel
